Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

Forgot your password?

Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.

I agree to TheMaven'sTerms andPolicy

Already have an account? Login here

JIM CRAMER INVESTING PERSONAL FINANCE RETIREMENT TECHNOLOGY MARKETS HOW-TO VIDEO FINANCIAL ADVISOR CENTER

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

ORIC Pharmaceuticals To Present At The 39th Annual J.P. Morgan Healthcare Conference

By GlobeNewswire
Jan 4, 2021 6:30 AM EST

ORIC Pharmaceuticals Announces Initiation Of Expansion Cohorts In Phase 1b Study Of ORIC-101

By GlobeNewswire
Dec 21, 2020 6:30 AM EST

ORIC Pharmaceuticals Announces Closing Of Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares

By GlobeNewswire
Nov 17, 2020 4:15 PM EST

ORIC Pharmaceuticals Announces Pricing Of Upsized Public Offering

By GlobeNewswire
Nov 13, 2020 6:32 AM EST

ORIC Pharmaceuticals Announces Proposed Public Offering Of Common Stock

By GlobeNewswire
Nov 10, 2020 4:05 PM EST

ORIC Pharmaceuticals To Participate In Upcoming Investor Conferences

By GlobeNewswire
Nov 9, 2020 6:30 AM EST

ORIC Pharmaceuticals Announces Presentation Of Preclinical Data On Glucocorticoid Receptor Antagonist Overcoming Resistance To An Androgen Receptor Degrader At The 32nd EORTC-NCI-AACR Symposium 2020

By GlobeNewswire
Oct 9, 2020 6:30 AM EDT

ORIC Pharmaceuticals To Participate In Upcoming Investor Conferences

By GlobeNewswire
Sep 2, 2020 4:30 PM EDT

ORIC Pharmaceuticals Expands Precision Oncology Pipeline With Exclusive Worldwide License To Highly Selective Allosteric PRC2 Inhibitors From Mirati Therapeutics

By GlobeNewswire
Aug 5, 2020 4:05 PM EDT

ORIC Pharmaceuticals To Host Second Quarter 2020 Financial Results Conference Call

By GlobeNewswire
Aug 3, 2020 10:15 PM EDT

ORIC Pharmaceuticals Appoints Lori Kunkel, M.D., To Its Board Of Directors

By GlobeNewswire
Jun 9, 2020 4:15 PM EDT

ORIC Pharmaceuticals Announces Five Presentations At The 2020 American Association For Cancer Research Virtual Annual Meeting II

By GlobeNewswire
May 27, 2020 6:30 AM EDT

ORIC Pharmaceuticals To Present At The Jefferies 2020 Global Healthcare Conference

By GlobeNewswire
May 26, 2020 6:30 AM EDT

ORIC Pharmaceuticals Announces Closing Of Initial Public Offering And Full Exercise Of Underwriters' Option To Purchase Additional Shares

By GlobeNewswire
Apr 28, 2020 4:30 PM EDT

ORIC Pharmaceuticals Presents Preclinical Data On CD73 Inhibitor At The American Association For Cancer Research (AACR) Virtual Annual Meeting

By GlobeNewswire
Apr 27, 2020 4:30 PM EDT

ORIC Pharmaceuticals Announces Pricing Of Initial Public Offering

By GlobeNewswire
Apr 23, 2020 8:56 PM EDT

Terms Of Use
Privacy Policy
Advertise
Reprints
Customer Service
Data
Topic Archive
Subscriptions

© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.